TPWA
UTHR icon

Twin Peaks Wealth Advisors’s United Therapeutics UTHR Stock Holding History

Twin Peaks Wealth Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.1K Buy
+49
New +$24.4K 0.01% 585
2025
Q3 		– Sell
-34
Closed -$10.2K – 2027
2025
Q2 		$10.2K Buy
+34
New +$10.2K ﹤0.01% 922

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Twin Peaks Wealth Advisors's UTHR Position: Q1 2026 in Review

Twin Peaks Wealth Advisors opened a new position in United Therapeutics (UTHR) in Q1 2026: 49 shares worth $29.1K. The stake represents 0.01% of the portfolio and ranks #585 among its holdings. This is a return to the name: Twin Peaks Wealth Advisors previously reported a position in UTHR as recently as Q2 2025.

Twin Peaks Wealth Advisors first reported a position in UTHR in Q2 2025 and has held it in 2 quarters since. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Twin Peaks Wealth Advisors held 49 shares of United Therapeutics worth $29.1K as of Q1 2026.
  • United Therapeutics was a new Twin Peaks Wealth Advisors position in Q1 2026.
  • United Therapeutics made up 0.01% of Twin Peaks Wealth Advisors's portfolio in Q1 2026, its #585 holding.
  • Twin Peaks Wealth Advisors first reported a position in United Therapeutics in Q2 2025 and has held it in 2 quarters since.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q1 2026, filed 8 May 2026.